4Nagahama H,Okads S,Okusaka T,et a1.Clinicalpathological features in misdiagnosed pancreatic carcinoma[J].Hepatogastroenterology,1999,46 (29):2983-2985.
二级参考文献9
1Wilentz R E，Cancer，1998年，82卷，96页
2Chang K J，Gastrointest Endosc，1997年，45卷，387页
3Fritscher-Ravens A, Sriram PV, Krause C, et al. Detection of pancreatic metastases by EUS-guided fine-needle aspiration. Gastrointest Endosc,2001,53:65-70.
4O'Reilly DA, Kingsnorth AN. Hereditary pancreatitis and mutationsof the cationic trypsinogen gene. Br J Surg, 2000,87: 708-717.
5Bhutani MS. Endoscopic ultrasound in pancreatic diseases. Gastroenterol Clin North Am, 1999,28: 747-770.
6O' Toole D, Palazzo L, Arotcarena R, et al. Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc,2001,53:470-474.
7Berberat P, Friess H, Kashiwagi M, et al. Diagnosis and staging ofpancreatic cancer by positron emission tomography. World J Surg,1999,23: 882-887.
8Theodor L, Melzer E, Sologov M, et al. Diagnostic value of K-rasmutations in serum of pancreatic cancer patients. Ann NY Acad Sci,2000,906:19-24.
9Myung SJ, Kim MH, Kim YS, et al. Telomerase activity in purepancreatic juice for the diagnosis of pancreatic cancer may be complementary to K ras mutation. Gastrointest Endosc, 2000, 51: 708-713.
